Bendemustine, Neulasta and Me - American Cancer Society

Well this was my first week of treatment. This is hard. Had Bendemustine Wednesday and Thursday with my shot of Neulasta yesterday. Have typical symptoms I think. Swollen still from Iv,I'm quite sure my eyes are in my face somewhere!, have some wierd ...

Expect the unexpected - FOX News

The issue could have been resolved, had I been willing to take an injection of Neulasta, the devil drug that "squeezes" your bone marrow, thereby releasing into your blood stream additional white blood cells. The description alone indicates the ...

Royalty Pharma Raises $600 Million of Debt - msnbc.com

Leading products in Royalty Pharma's portfolio include: Abbott's Humira®, Johnson and Johnson's Remicade® and Prezista®, Gilead's Atripla®, Truvada®, Complera® and Emtriva®, Pfizer's Lyrica®, Amgen's Neupogen® and Neulasta®, Genentech's Rituxan ...

new to board - American Cancer Society

I then started chemotherapy for 6 cycles every 3 weeks and herceptin every week and neulasta every 3 weeks. i finished chemo on March 22, 2012 and now i am taking the herceptin infusion every 3 weeks until december. I was going to start tamoxifen ...

RNCOS Releases a New Report - G-CSF Biosimilars Market Forecast to 2015 - SBWire

It is expected that the patent expiries of Neupogen (filgrastim) in 2013 and Neulasta (pegfilgrastim) in 2015 will make the way for the entry of G-CSF biosimilars into the market. It is anticipated that the G-CSF biosimilars market will touch ...

Amgen Beats but Maintains Outlook - Yahoo Finance

We note that a new competitor, Affymax’ (AFFY) Omontys (peginesatide), has entered the dialysis market. Worldwide revenues of Neulasta and Neupogen grew 9% to $1,344 million in the first quarter. An increase in average net sales price and unit ...